Fadraciclib-Standard-生命科学试剂-MCE.pdfVIP

  • 0
  • 0
  • 约2.11千字
  • 约 1页
  • 2026-01-30 发布于上海
  • 举报

Hotline:400-820-3792

Inhibitors•ScreeningLibraries•Proteins

www.MedChemE

Fadraciclib(Standard)

Cat.No.:HY-101212R

CASNo.:1070790-89-4

分⼦式:C₂₁H₃₁N₇O

分⼦量:397.52

作⽤靶点:CDK;ReferenceStandards

作⽤通路:CellCycle/DNADamage;Others

储存⽅式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

⽣物活性Fadraciclib(Standard)是Fadraciclib(HY-101212)的分析标准品。本产品⽤于研究及分析应⽤。Fadraciclib

(CYC065)是第⼆代⼝服有效的ATP竞争性的CDK2/CDK9激酶抑制剂[1],IC50分别为5和26nM[2]。

IC50TargetCDK2/CDK9[1]

REFERENCES

[1].CoccoE,etal.DualCCNE1/PIK3CAtargetingissynergisticinCCNE1-amplified/PIK3CA-mutateduterineserouscarcinomasinvitro

andinvivo.BrJCancer.2016Jul26;115(3):303-11.

[2].SumanaDevata,etal.Molecularmarkersandvenousthromboembolism(VTE)inacutemyelogenousleukemia(AML)

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE

1/1

文档评论(0)

1亿VIP精品文档

相关文档